Bill Commons

FL SB 1638

dead

Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs

Florida · 2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did FL SB 1638 pass?

No. FL SB 1638 did not pass — it was defeated or died in the legislative process. Latest recorded action (2026-03-13): Died in Banking and Insurance

What is FL SB 1638 about?

Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs; Prohibiting drug manufacturers from engaging in certain acts relating to the acquisition of 340B drugs by and the delivery of such drugs to specified pharmacies; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of such insurers and health maintenance organizations, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs, etc.

Who sponsors FL SB 1638?

Jones is the primary sponsor of FL SB 1638.

Description

Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs; Prohibiting drug manufacturers from engaging in certain acts relating to the acquisition of 340B drugs by and the delivery of such drugs to specified pharmacies; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of such insurers and health maintenance organizations, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs, etc.

Introduced
2026-01-22
Latest action
2026-03-13 — Died in Banking and Insurance
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Jonesprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-03-13

    Died in Banking and Insurance

    failure

  2. 2026-01-22

    Introduced

    introduction

  3. 2026-01-16

    Referred to Banking and Insurance; Health Policy; Rules

    referral-committee

  4. 2026-01-09

    Filed

    filing

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:19:20.677932Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=FL&identifier=SB 1638. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.